Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2022-01-11 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
2022年限制性股票激励计划实施考核管理办法
Board/Management Information Classification · 85% confidence The document is titled as the '2022 Restricted Stock Incentive Plan Implementation Assessment Management Measures' for Yingkang Life Technology Co., Ltd. It details the company's internal rules and procedures for assessing the performance related to a restricted stock incentive plan, including governance structure, assessment principles, performance indicators, and procedures. It is a policy or management document related to stock incentive plans rather than a financial report, earnings release, or regulatory filing. It does not contain financial statements or audit information, nor is it an announcement of voting results or a proxy statement. It is focused on management and governance of incentive plans, which aligns best with Board/Management Information (MANG) as it relates to management policies and internal governance mechanisms regarding stock incentives.
2022-01-11 Chinese
股东大会议事规则(2022年1月）
Governance Information Classification · 95% confidence The document is titled as the "Shareholders' Meeting Rules" of 盈康生命科技股份有限公司 (Yingkang Life Technology Co., Ltd.) dated January 2022. It extensively details the procedures, powers, and regulations governing the company's shareholders' meetings, including the convening, proposal submission, voting, and resolution processes. It references legal frameworks such as the Company Law of the People's Republic of China and the company's Articles of Association. The content is focused on governance rules for shareholder meetings rather than reporting financial results, management changes, or announcements of voting outcomes. It is not a report of voting results, nor an announcement of a meeting or report publication. It is a governance document outlining internal rules and procedures for shareholder meetings. Therefore, the most appropriate classification is Governance Information (CGR).
2022-01-11 Chinese
关于公司董事、高级管理人员变动的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding changes in the company's board of directors and senior management, specifically the resignation of a director and a vice general manager. It includes details about the impact on the board size and related corporate governance matters. There is no financial data, earnings information, or report publication mentioned. The content fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, confirming the classification.
2022-01-11 Chinese
关于回购公司股份实施完成暨股份变动的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the completion of a share repurchase program by the company 盈康生命科技股份有限公司. It details the number of shares repurchased, the price range, the total amount spent, compliance with the repurchase plan, and the intended use of the repurchased shares for employee incentive plans. It also confirms that the repurchase plan has been fully implemented and provides information on the compliance and legal aspects of the repurchase. There are no financial statements or detailed financial analysis included, and the document is relatively short (2681 characters). This fits the description of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares.
2022-01-11 Chinese
关于全资子公司向中国青年创业就业基金会捐赠的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company about a donation made by its wholly-owned subsidiary to a foundation. It details the donation purpose, the recipient, and the impact on the company. The document is short (1250 characters) and does not contain financial statements, audit information, or detailed financial data. It is not a report but an announcement of a corporate social responsibility action. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is a regulatory announcement about a corporate event that does not involve board changes, financing, or voting results. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-01-11 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is titled as an announcement regarding the progress of the company's share repurchase plan. It details the number of shares repurchased, prices, compliance with regulations, and the timeline of the repurchase program. It does not contain financial statements or earnings data but focuses on the company's buyback activities. The document length is short (1393 characters) and it is clearly an update on share repurchase progress, which fits the definition of a Transaction in Own Shares (POS) filing rather than a full financial report or other categories.
2022-01-04 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.